Digital is Unleashing the Power of our People
Digital is transforming every aspect of our business at Pfizer – from the way we discover and develop medicines, to the way we improve health outcomes and the way we do our work faster and easier – so we can deliver breakthroughs as quickly as possible. “We are simplifying and automating transactional processes to make room for meaningful work,” said Lidia Fonseca, Chief Digital and Technology Officer, Pfizer. “And, we are providing access to cutting-edge learning experiences that prepare colleagues for the future, so they can develop innovations that drive our purpose.”
In 2019, we identified 100 million annual transactions primed for automation and, by the end of 2021, we automated 90 percent of our transaction volume, exceeding our goal of 75 percent. We have delivered hundreds of automations across the company that empower our colleagues, allowing them to focus on their highest priority work. In finance and global business services, we deployed more than 300 robotic process automations that have decreased manual process errors and improved process throughput. Our sales representatives can now scan bar codes to quickly add a sample during a sales call and monitor inventory quantities, a first-in-industry solution that creates a better experience and eliminates potential errors.
We know that to innovate on behalf of our patients, we must prepare Pfizer colleagues for the future, continuously broadening their skill sets. In 2021, we launched the new Pfizer Learning Academy, a state-of-the-art experience powered by machine learning that adapts to each colleague’s unique learning needs. It includes personalized recommendations, insights and resources based on the colleague’s current role and aspirations. Colleagues can access the Academy on multiple devices to learn anywhere, anytime. The experience includes social and collaborative learning, allowing colleagues to share recommendations. The Pfizer Learning Academy is transforming learning at Pfizer and is a catalyst toward a learner-led culture that enables all colleagues to maximize their potential while helping achieve our Purpose and Bold Moves.
Technology has even touched the expansion of the Pfizer footprint. In October 2021, we officially opened a new facility in Thessaloniki, Greece, which includes the Center for Digital Innovation (CDI). The CDI has already been instrumental in creating state-of-the-art solutions to improve patient outcomes, while also sourcing the best talent from around the world. Three hundred and fifty highly qualified colleagues with cutting-edge digital skills and competencies in machine learning, artificial intelligence, data science, robotic process automation, agile project management, cybersecurity, cloud, and architecture joined the Pfizer family. In fact, we are creating a new, leading-edge center of excellence in quantum computing, an up-and-coming field that we believe will accelerate innovation to enhance patient health outcomes.
Pfizer colleagues are staying ahead of the curve, leveraging the best of digital, data, and technology to power science and innovation in support of our purpose: breakthroughs that change patients’ lives.
